The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole
Abstract Background Fluconazole (FLC) is a widely used antifungal agent; however, Candida albicans is increasingly developing resistance to it. Given the limited range of available antifungal drugs, there is an immediate requirement for the development of novel approaches to improve FLC efficacy aga...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2026-01-01
|
| Σειρά: | BMC Microbiology |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12866-025-04701-1 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|